|
Title
|
Published
|
Price
|
|
Pharmaceutical Digital Marketing and Social Media
By: Cutting Edge Information
... digital activity, and growth trends indicate that some digital channels will surpass more traditional media tools. But as the industry explores this new territory, questions loom about regulatory compliance, ROI, adverse events monitoring and other ...
|
more...
|
11/1/2011
|
$7,695.00
|
|
Health Outcomes Liaisons: Managing a Field-Based Team that Speaks the Payer’s Language
By: Cutting Edge Information
... with payers and secure the best reimbursement, companies increasingly deploy health outcomes liaisons (HOLs). HOLs forge connections with key target audiences by communicating critical health economics and outcomes research (HEOR) data. Trailblazing companies have assembled ...
|
more...
|
10/1/2011
|
$7,695.00
|
|
KOL Fair-Market Value and Aggregate Spend
By: Cutting Edge Information
... of the Sunshine Act is already being felt as pharmaceutical, biotechnology and medical device companies invest millions of dollars to implement aggregate spend tracking systems. These systems are critical components in remaining compliant and meeting ...
|
more...
|
10/1/2011
|
$7,695.00
|
|
Investigator Initiated Trial Management
By: Cutting Edge Information
... publication in a medical journal to advance a drug’s — and the company’s — profile and credibility. Supported by dedicated resources, effective IIT teams reach that point by navigating process delays while maintaining regulatory compliance ...
|
more...
|
9/1/2011
|
$7,695.00
|
|
Succession Planning: Preparing Tomorrow’s Leaders
By: Cutting Edge Information
... a plan or do not update it regularly - leaving them vulnerable and unprepared for change. Part of ongoing excellence, however, is resilience. Forward-looking companies see succession planning as an opportunity to reinforce corporate identity, ...
|
more...
|
9/1/2011
|
$995.00
|
|
Market Access Management: Building Teams that Deliver Value to Payers
By: Cutting Edge Information
... these teams must harness resources and advance objectives across an incredible network of stakeholders - everyone from internal subfunctions to other major departments to external customers both private and public. In short, market access groups ...
|
more...
|
8/1/2011
|
$7,695.00
|
|
Phase IV Clinical Trials
By: Cutting Edge Information
... IV studies are a growing necessity — but they often remain deprioritized and under-resourced as teams struggle to marshal needed support for both strategy and execution. Use this study to reinforce Phase IV research and ...
|
more...
|
7/1/2011
|
$7,695.00
|
|
Pharmaceutical Business Development and Licensing
By: Cutting Edge Information
... for example, as well as patent expirations, pipeline setbacks and other challenges. Smaller organizations may have wizards in the lab — but limited infrastructure and resources to commercialize their innovations. Superior business development teams address ...
|
more...
|
6/1/2011
|
$7,695.00
|
|
Pharmaceutical Marketing Strategy: Key ROI Benchmarks to Drive Brand Success
By: Cutting Edge Information
... — and they prioritize elements in their marketing mixes based on the impact of each activity, channel or promotional tool. Discover how 28 top pharmaceutical and biotech teams have built their products’ marketing plans, then ...
|
more...
|
5/1/2011
|
$7,695.00
|
|
Pharmaceutical Pricing Strategy
By: Cutting Edge Information
... Discover how leading life sciences companies find and justify prices in light of heightened pressures from government payers and stringent economic policies. Explore in-depth benchmarks and insights, culled from over 30 pharmaceutical, biotechnology, and medical ...
|
more...
|
4/1/2011
|
$7,695.00
|
|
Medical Affairs
By: Cutting Edge Information
... on the ultimate goals of any medical group - to generate, package and disseminate medical and clinical information for both internal and external clients. To accomplish this mission, the modern medical affairs department has evolved ...
|
more...
|
1/1/2011
|
$7,695.00
|
|
Specialty and Hospital Sales Force Management (PH151)
By: Cutting Edge Information
... business is done — throughout hospitals and in each doctor’s office. Successful sales professionals create personal relationships with physicians, uncover new ways to reach targets and understand how to navigate the evolving healthcare environment. As ...
|
more...
|
1/1/2011
|
$7,695.00
|
|
Clinical Operations: Benchmarking Per-Patient Trial Costs, Staffing and Adaptive Design
By: Cutting Edge Information
... causing drugmakers to adopt a bottom-line perspective and demand greater R&D efficiency. Greater efficiency leads to cost- and time-savings that could mean the difference in beating the competition to market and adding time to a ...
|
more...
|
1/1/2011
|
$7,695.00
|
|
Determining European KOL Compensation Fair-Market Value Benchmarks
By: Cutting Edge Information
... are now applying similar approaches to Europe and other parts of the world. To remain compliant with government regulations, industry codes and various agencies’ guidelines, drug and device companies must understand the fair-market value (FMV) ...
|
more...
|
1/1/2011
|
$7,695.00
|
|
Strategic Pharmaceutical Competitive Intelligence
By: Cutting Edge Information
... groups through the tough times are gradually increasing resources for CI. Furthermore, they’re elevating these teams’ strategic positioning to deliver maximum impact. Competitive intelligence teams succeed when they’re visible, report to strategic planners and C-level ...
|
more...
|
11/1/2010
|
$7,695.00
|
|
Emerging Markets Clinical Development Series Brazil, Russia, India and China (BRIC)
By: Cutting Edge Information
... (or recruitment challenges) that plague studies in North America and Western Europe, unparalleled access to untapped patient populations, and new opportunities to meet the growing medical needs of these countries. Despite vast promise as the ...
|
more...
|
11/1/2010
|
$7,695.00
|
|
Emerging Markets Clinical Development Series Africa
By: Cutting Edge Information
... But Africa offers tremendous expertise and opportunity for drug and device companies looking for cost-effective study sites and appropriate patient populations. As challenging as Africa may seem, drug companies have made commitments to improve healthcare ...
|
more...
|
11/1/2010
|
$7,695.00
|
|
Medical Device Competitive Intelligence
By: Cutting Edge Information
... proper resource support, CI teams at device companies may never reach the level of sophistication seen at other life sciences or consumer products organizations. In short, device companies can be doing much more to boost ...
|
more...
|
11/1/2010
|
$7,695.00
|
|
Emerging Markets Clinical Development Series Asia (China, India, Other Emerging Asian Countries)
By: Cutting Edge Information
... among investigators has come in-line with Western expectations for Good Clinical Practice. Asia presents an interesting mix of Western knowledge and Eastern practice that has resulted in significant scientific and medical advances. As more companies ...
|
more...
|
11/1/2010
|
$7,695.00
|
|
Emerging Markets Clinical Development Series Central and Eastern Europe
By: Cutting Edge Information
... clinical studies. In fact, the population of Central and Eastern European countries exceeds that of either the United States or the five largest Western European markets combined. Furthermore, there is a lower saturation of competing ...
|
more...
|
11/1/2010
|
$7,695.00
|
|
Pharmaceutical Lifecycle Management
By: Cutting Edge Information
... investments — drug companies devise robust strategies to prolong brand life and value. Successful teams plan carefully — and give themselves plenty of time to execute their strategies, which may take years to bear fruit. ...
|
more...
|
9/1/2010
|
$7,695.00
|
|
Best Practices in MSL Team Management
By: Cutting Edge Information
... to shape clinical and commercial strategy. These responsibilities have amplified the professional and educational experience required of MSLs, and superlative MSL management now requires a deft balancing act that includes resource planning, HR concerns and ...
|
more...
|
7/1/2010
|
$7,695.00
|
|
Health Economics and Outcomes Research US, Europe, Canada and Emerging Markets
By: Cutting Edge Information
... and outcomes research (HEOR) goals and management. Five chapters are chock-full of data and expert advice focused on these primary areas: Structure and reporting relationships Spending, budgets and ROI Staffing and compensation Activities, timelines and ...
|
more...
|
7/1/2010
|
$7,695.00
|
|
Countering Generic and Biosimilar Threats
By: Cutting Edge Information
... billion. To retain market share in the battle against generics, brands must devise a well-rounded strategy. But knowing which moves to make - and when - is no easy task, and decisions on how much ...
|
more...
|
6/1/2010
|
$7,695.00
|
|
The New MSL Profile: Thought Leader, External Voice and Clinical Catalyst
By: Cutting Edge Information
... skills make them unique assets for any life sciences company. As their contributions increase, however, so has confusion about the MSL role. Forward-thinking companies focus MSL talent by defining MSL priorities and communicating their capabilities ...
|
more...
|
5/1/2010
|
$7,695.00
|
|
Title
|
Published
|
Price
|
(0 items)
